SideFX
Log inGet started
SideFX

Track symptoms, monitor medications, and understand patterns in your health data. For personal use only โ€” not medical advice.

Product

  • Dashboard
  • Reports
  • Log Symptom
  • Drug Search

Company

  • About
  • Sign up
  • Sign in

Legal

  • Privacy Policy
  • Terms of Service

ยฉ 2026 GermFx. All rights reserved.

PrivacyยทTermsยทContact

Health News

Browse recent medication, recall, and health-related stories.

Page 47 of 51

Sort news

Zulum woos investors, assures support for pharmaceutical industry

Borno State Governor, Professor Babagana Umara Zulum, on Monday, held high-level discussions with prospective investors in the trade, mining, and pharmaceutical industries to attract private-sector investment to the state. During a visit to the office of the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC) in Abuja, Governor Zulum The post Zulum woos investors, assures support for pharmaceutical industry appeared first on National Accord Newspaper .

thenationonlineng7/14/2026
thenationonlineng7/14/2026

Zulum woos investors, assures support for pharmaceutical industry

Borno State Governor, Professor Babagana Umara Zulum, on Monday, held high-level discussions with prospective investors in the trade, mining, and pharmaceutical industries to attract private-sector investment to the state. During a visit to the office of the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC) in Abuja, Governor Zulum The post Zulum woos investors, assures support for pharmaceutical industry appeared first on National Accord Newspaper .

Read article

Coffee warning for anyone using new weight-loss drugs

A pharmacist says people may not be fully aware of the rules they have to follow

gloucestershirelive7/14/2026

Idiopathic Pulmonary Fibrosis (IPF) Treatment is Entering its Most Competitive Era Yet - What Thelansis Data Reveals

Executive Summary Idiopathic Pulmonary Fibrosis remains one of the toughest fights in respiratory medicine. It's a progressive, irreversible scarring of lung tissue with a median survival window that, sobering as it sounds, published clinical literature describes as worse than that of

openpr7/14/2026

AstraZeneca pays $600m for Chinese lung cancer drug rights

investing_in7/14/2026

AstraZeneca to license lung cancer drug from China's Dizal Pharmaceutical

reuters_com7/14/2026

Retinitis Pigmentosa in 2026: Mapping the Shift from Supportive Care to Restorative Therapy, Thelansis Reports

Retinitis Pigmentosa (RP) has spent the better part of a decade waiting for its "next Luxturna moment." In 2026, that moment finally looks close, several late-stage programs are reporting durability data, filing timelines are firming up, and for the first

openpr7/14/2026

'I was a size 22 and now I'm a 12 - my TikTok videos fund my weight-loss jabs'

Amy Carding, 38, has lost 5st 8lb in 18 months after taking Mounjaro

liverpoolecho7/14/2026
C

Can Ozempic prevent cancer? A doctor explains why the headlines are easy to misread

Ozempic and other GLP-1 drugs are generating headlines for supposedly preventing cancer, but current evidence does not justify that claim. Large observational studies hint at reduced risks for some cancers and higher risk for kidney cancer, yet biases, short follow-up.

downtoearth7/14/2026

Need support? Hereโ€™s where Utahns can turn for help

Many people know they or someone they love needs help, but they have no idea where to start.The words behavioral health hospital, inpatient treatment, resident

kutv7/13/2026

Overheard with Ajay Raju featuring Dr. David Fajgenbaum

What if the cure for your disease was already sitting on a drugstore shelf? That's the audacious premise driving Dr. David Fajgenbaum, physician-scientist, Penn Medicine researcher, and co-founder of Every Cure, whose life story is as extraordinary as his science.

6abc7/13/2026
โ† PreviousNext โ†’
gloucestershirelive7/14/2026

Coffee warning for anyone using new weight-loss drugs

A pharmacist says people may not be fully aware of the rules they have to follow

Read article
openpr7/14/2026

Idiopathic Pulmonary Fibrosis (IPF) Treatment is Entering its Most Competitive Era Yet - What Thelansis Data Reveals

Executive Summary Idiopathic Pulmonary Fibrosis remains one of the toughest fights in respiratory medicine. It's a progressive, irreversible scarring of lung tissue with a median survival window that, sobering as it sounds, published clinical literature describes as worse than that of

Read article
investing_in7/14/2026

AstraZeneca pays $600m for Chinese lung cancer drug rights

Read article
reuters_com7/14/2026

AstraZeneca to license lung cancer drug from China's Dizal Pharmaceutical

Read article
openpr7/14/2026

Retinitis Pigmentosa in 2026: Mapping the Shift from Supportive Care to Restorative Therapy, Thelansis Reports

Retinitis Pigmentosa (RP) has spent the better part of a decade waiting for its "next Luxturna moment." In 2026, that moment finally looks close, several late-stage programs are reporting durability data, filing timelines are firming up, and for the first

Read article
liverpoolecho7/14/2026

'I was a size 22 and now I'm a 12 - my TikTok videos fund my weight-loss jabs'

Amy Carding, 38, has lost 5st 8lb in 18 months after taking Mounjaro

Read article
C
downtoearth7/14/2026

Can Ozempic prevent cancer? A doctor explains why the headlines are easy to misread

Ozempic and other GLP-1 drugs are generating headlines for supposedly preventing cancer, but current evidence does not justify that claim. Large observational studies hint at reduced risks for some cancers and higher risk for kidney cancer, yet biases, short follow-up.

Read article
kutv7/13/2026

Need support? Hereโ€™s where Utahns can turn for help

Many people know they or someone they love needs help, but they have no idea where to start.The words behavioral health hospital, inpatient treatment, resident

Read article
6abc7/13/2026

Overheard with Ajay Raju featuring Dr. David Fajgenbaum

What if the cure for your disease was already sitting on a drugstore shelf? That's the audacious premise driving Dr. David Fajgenbaum, physician-scientist, Penn Medicine researcher, and co-founder of Every Cure, whose life story is as extraordinary as his science.

Read article